Related references
Note: Only part of the references are listed.Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study
Chao-Han Lai et al.
RHEUMATOLOGY (2020)
Comparative Risks of Cardiovascular Disease in Patients With Systemic Lupus Erythematosus, Diabetes Mellitus, and in General Medicaid Recipients
Medha Barbhaiya et al.
ARTHRITIS CARE & RESEARCH (2020)
Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014
Marc Scherlinger et al.
AUTOIMMUNITY REVIEWS (2020)
Metabolic syndrome in systemic lupus erythematosus was closely related to body mass index, blood pressure, blood sugar, blood lipids, and arthritis
Lai-Run Jin et al.
PAKISTAN JOURNAL OF MEDICAL SCIENCES (2020)
Progression of atherosclerosis versus arterial stiffness with age within and between arteries in systemic lupus erythematosus
Paola C. Roldan et al.
RHEUMATOLOGY INTERNATIONAL (2019)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
A Meta-Analysis of Cardiovascular Events in Systemic Lupus Erythematosus
Ming-Ming Gu et al.
IMMUNOLOGICAL INVESTIGATIONS (2019)
Inflammatory, Serological and Vascular Determinants of Cardiovascular Disease in Systemic Lupus Erythematosus Patients
Valentina Mercurio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Smoking-induced risk of future cardiovascular disease is partly mediated by cadmium in tobacco: Malmo Diet and Cancer Cohort Study
Huiqi Li et al.
ENVIRONMENTAL HEALTH (2019)
The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts
M. Frodlund et al.
LUPUS (2019)
Heart failure risk in systemic lupus erythematosus compared to diabetes mellitus and general medicaid patients
Sarah K. Chen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Exploring Unconventional Risk-Factors for Cardiovascular Diseases: Has Opioid Therapy Been Overlooked?
Oluwabunmi Ogungbe et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
Systemic Lupus Erythematosus and Increased Prevalence of Atherosclerotic Cardiovascular Disease in Hospitalized Patients
Gregory Katz et al.
MAYO CLINIC PROCEEDINGS (2019)
Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity
Samar M. Hammad et al.
PLOS ONE (2019)
Development of a systemic lupus erythematosus cardiovascular risk equation
Michelle A. Petri et al.
LUPUS SCIENCE & MEDICINE (2019)
Inhibition of PAI (Plasminogen Activator Inhibitor)-1 Improves Brain Collateral Perfusion and Injury After Acute Ischemic Stroke in Aged Hypertensive Rats
Siu-Lung Chan et al.
STROKE (2018)
Hypertension Enhances Advanced Atherosclerosis and Induces Cardiac Death in Watanabe Heritable Hyperlipidemic Rabbits
Bo Ning et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Incidence and variables associated with short and long-term mortality in patients with systemic lupus erythematosus and sepsis admitted in intensive care units
E. Abramovich et al.
LUPUS (2018)
Self-Reported Physical Activity Is Associated with Lupus Nephritis in Systemic Lupus Erythematosus: Data from KORean Lupus Network (KORNET) Registry
Seong-Kyu Kim et al.
YONSEI MEDICAL JOURNAL (2018)
Systemic lupus erythematosus is a risk factor for cardiovascular disease: a nationwide, population-based study in Korea
S. Y. Lim et al.
LUPUS (2018)
Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus
Monica Vazquez-Del Mercado et al.
PLOS ONE (2018)
Myocarditis in systemic lupus erythematosus diagnosed by 18F-fluorodeoxyglucose positron emission tomography
Alexandra Perel-Winkler et al.
LUPUS SCIENCE & MEDICINE (2018)
Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis
Vitor Teixeira et al.
FRONTIERS IN MEDICINE (2018)
Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus
Jyoti Bakshi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)
Hydroxychloroquine in systemic lupus erythematosus (SLE)
C. Ponticelli et al.
EXPERT OPINION ON DRUG SAFETY (2017)
Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus
Konstantinos Tziomalos et al.
RHEUMATOLOGY INTERNATIONAL (2017)
Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study
Abdulla Watad et al.
IMMUNOLOGIC RESEARCH (2017)
Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study
Konstantinos Tselios et al.
JOURNAL OF RHEUMATOLOGY (2017)
Effect of low and high HDL-C levels on the prognosis of lupus nephritis patients: a prospective cohort study
Peiran Yin et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study
J. Antonio Avina-Zubieta et al.
ARTHRITIS CARE & RESEARCH (2017)
Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus
Medha Barbhaiya et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls
Johanna T. Gustafsson et al.
PLOS ONE (2017)
Stroke in systemic lupus erythematosus: a Swedish population-based cohort study
Elizabeth V. Arkema et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence
Douglas E. Vaughan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis
Maria G. Tektonidou et al.
AUTOIMMUNITY REVIEWS (2017)
Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosus
T. P. Mikolajczyk et al.
LUPUS (2016)
Systemic lupus erythematosus and atherosclerosis: Review of the literature
Marianne Frieri et al.
AUTOIMMUNITY REVIEWS (2016)
Risk of Peripheral Arterial Occlusive Disease in Patients With Systemic Lupus Erythematosus A Nationwide Population-Based Cohort Study
Ya-Wen Chuang et al.
MEDICINE (2015)
Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis
Flavia Ballocca et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
Low High-Density Lipoprotein and Risk of Myocardial Infarction
A. Ramirez et al.
CLINICAL MEDICINE INSIGHTS-CARDIOLOGY (2015)
Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies
Marie Holmqvist et al.
RMD OPEN (2015)
B-cell-targeted therapies in systemic lupus erythematosus
Vera Sau-Fong Chan et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Peripheral arterial disease in patients with systemic lupus erythematosus: a prospective controlled study
Ayman A. Hassan et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2013)
The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: A systematic review
Sara R. Schoenfeld et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
Incidence of and Risk Factors for Adverse Cardiovascular Events Among Patients With Systemic Lupus Erythematosus
Laurence S. Magder et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Importance of high-density lipoprotein-cholesterol (HDL-C) levels to the incidence of cardiovascular disease (CVD) in the elderly
Elizabete Viana de Freitas et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2011)
High Risk of Ischemic Heart Disease in Patients with Lupus Nephritis
Mikkel Faurschou et al.
JOURNAL OF RHEUMATOLOGY (2011)
Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE
Deborah P. M. Symmons et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Anti-Apolipoprotein A-1 IgG Predicts Major Cardiovascular Events in Patients With Rheumatoid Arthritis
Nicolas Vuilleumier et al.
ARTHRITIS AND RHEUMATISM (2010)
The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases
Armen Yuri Gasparyan et al.
Current Vascular Pharmacology (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
B cells as therapeutic targets in SLE
Inaki Sanz et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus
Guillermo J. Pons-Estel et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Atherosclerotic Vascular Events in a Multinational Inception Cohort of Systemic Lupus Erythematosus
M. B. Urowitz et al.
ARTHRITIS CARE & RESEARCH (2010)
Dysfunctional Proinflammatory High-Density Lipoproteins Confer Increased Risk of Atherosclerosis in Women With Systemic Lupus Erythematosus
Maureen McMahon et al.
ARTHRITIS AND RHEUMATISM (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic US cohort (LXIX)
P. I. Burgos et al.
LUPUS (2009)
Mortality in systemic lupus erythematosus
S. Bernatsky et al.
ARTHRITIS AND RHEUMATISM (2006)
Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients
R Cervera et al.
MEDICINE (2003)
Mortality and causes of death in systemic lupus erythematosus
J Trager et al.
CURRENT OPINION IN RHEUMATOLOGY (2001)
Share Paper
